-
Full Article (HTML) (110) -
Full Article (PDF) (45) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4955)
All Articles published online
|
Publishing Process of This Article
|
Jun 24, 2016 (publication date) through Aug 11, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Byrne TJ, Rakela J. Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy. World J Transplant 2016; 6(2): 306-313 [PMID: 27358775 DOI: 10.5500/wjt.v6.i2.306] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i2/306.htm |
| Number | Citing Articles |
| 1 |
Sophia Schmitz, Georg Lurje, Florian Ulmer, Anne Andert, Philipp Bruners, Maximilian Schulze-Hagen, Ulf Neumann, Wenzel Schoening. Loco-regional hepatocellular carcinoma treatment services as a bridge to liver transplantation. Hepatobiliary & Pancreatic Diseases International 2019; 18(3): 228 doi: 10.1016/j.hbpd.2019.01.004
|
| 2 |
Ana-Maria Bucalau, Illario Tancredi, Gontran Verset. In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?. Cancers 2021; 13(20): 5129 doi: 10.3390/cancers13205129
|
| 3 |
|
| 4 |
Allison N. Martin, Luke R. Wilkins, Deepanjana Das, Lily E. Johnston, Todd W. Bauer, Reid B. Adams, Victor M. Zaydfudim. Efficacy of Radiofrequency Ablation versus Transarterial Chemoembolization for Patients with Solitary Hepatocellular Carcinoma ≤3 cm. The American Surgeon 2019; 85(2): 150 doi: 10.1177/000313481908500220
|
| 5 |
Anum Aslam, Amita Kamath, Bradley Spieler, Mark Maschiocchi, Carl F. Sabottke, Victoria Chernyak, Sara C. Lewis. Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents. Abdominal Radiology 2021; 46(8): 3565 doi: 10.1007/s00261-021-03076-x
|
| 6 |
Zhenru Zhu, Chuanhui Cao, Dongyan Zhang, Zhihong Zhang, Li Liu, Dehua Wu, Jingyuan Sun. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism. Cell Death & Disease 2022; 13(2) doi: 10.1038/s41419-022-04596-0
|
| 7 |
Sandeep A. Ponniah, Andreas G. Zori, Roniel Cabrera. Liver Cancer. 2021; : 127 doi: 10.36255/exonpublications.livercancer.2021.ch7
|
| 8 |
William C. Chapman, Kevin M. Korenblat, Kathryn J. Fowler, Nael Saad, Adeel S. Khan, Vijay Subramanian, Maria B. Majella Doyle, Leigh Anne Dageforde, Benjamin Tan, Patrick Grierson, Yiing Lin, Min Xu, Elizabeth M. Brunt. Hepatocellular carcinoma: Where are we in 2018?. Current Problems in Surgery 2018; 55(11): 450 doi: 10.1067/j.cpsurg.2018.10.002
|
| 9 |
Alberto Unzueta, Roniel Cabrera. Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma. Clinics in Liver Disease 2017; 21(2): 231 doi: 10.1016/j.cld.2016.12.002
|
| 10 |
Won Chang, Jeong Min Lee, Jeong Hee Yoon, Dong Ho Lee, Sang Min Lee, Kyoung Bun Lee, Bo Ram Kim, Tae-Hyung Kim, Seunghyun Lee, Joon Koo Han, Gianfranco D. Alpini. No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine livers. PLOS ONE 2017; 12(4): e0176350 doi: 10.1371/journal.pone.0176350
|
| 11 |
Hla-Hla Thein, Wanrudee Isaranuwatchai, Yao Qiao, Kenny Wong, Gonzalo Sapisochin, Kelvin K. W. Chan, Eric M. Yoshida, Craig C. Earle. Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian setting. Cancer Medicine 2017; 6(9): 2017 doi: 10.1002/cam4.1119
|